Common Questions

Common indications include medically refractory disease, fibrotic stricture causing obstruction, penetrating complications (abscess, fistula, free perforation), hemorrhage, and dysplasia or malignancy. Surgery is generally considered when disease is anatomically limited and medical therapy has failed or is unlikely to reverse an established stricture.

Resection is favored for a single, actively inflamed or diseased segment, particularly when malignancy risk or perforation is a concern; strictureplasty is favored for multiple short strictures, especially in patients with limited bowel length or extensive prior resections, to preserve intestinal length. Long, actively inflamed strictures are generally poor strictureplasty candidates.

Endoscopic recurrence at the neoterminal ileum is common within the first year after resection, though clinical recurrence lags behind and develops more gradually. Recurrence risk is influenced by smoking status, prior resections, penetrating disease phenotype, and postoperative prophylactic therapy.

There is ongoing interest in anastomotic configuration and recurrence. The Kono-S anastomosis has been studied specifically for its potential to reduce mesenteric-side recurrence compared with conventional side-to-side anastomosis, though data continues to accumulate and practice varies by center.

Extended mesenteric excision has been proposed to reduce surgical recurrence based on the observation that mesenteric inflammation tracks with disease activity, and this remains an active area of study and evolving practice rather than a uniformly settled standard.

Pelvic MRI and/or exam under anesthesia are used to characterize fistula anatomy, sphincter involvement, and associated abscess or sepsis before deciding between seton drainage, definitive fistula repair, or a staged approach combined with biologic therapy.

Diversion is generally considered for severe, refractory perianal sepsis, extensive tissue destruction, poor sphincter function, or as a bridge to allow healing before attempting definitive repair or when quality of life is severely affected by uncontrolled perianal disease.

Anti-TNF and other biologic therapy is generally continued through minor procedures such as seton placement, while timing around major resection is individualized based on infection risk, disease activity, and nutritional status. Trough levels and recent dosing history are often factored into planning.

Bowel-preserving strategies, strictureplasty over resection, conservative resection margins, and multidisciplinary nutrition planning, become increasingly important as cumulative resection length grows, given the risk of short bowel syndrome with repeated Crohn's surgery.

Yes. Isolated ileal disease is typically managed with ileocolic resection, while colonic Crohn's disease may require segmental resection, total abdominal colectomy, or occasionally proctocolectomy, depending on distribution, rectal involvement, and perianal disease status.

Unlike oncologic resection, Crohn's disease resection margins are typically based on grossly normal, non-diseased bowel rather than a fixed histologic margin, since microscopic disease at the margin has not been consistently shown to predict recurrence.

Minimally invasive approaches are generally preferred when feasible and are associated with faster recovery, though a thickened, adherent mesentery or dense inflammatory phlegmon can necessitate conversion to open surgery, and this should be discussed with patients preoperatively.

Colonoscopy within roughly 6-12 months after resection (per Rutgeerts scoring) is standard to guide postoperative prophylactic therapy, alongside risk stratification based on smoking status, phenotype, and prior surgical history.

Management typically requires controlling sepsis first (drainage, sometimes diversion), optimizing nutrition, and addressing active disease medically before definitive resection of the diseased segment and fistula tract, since operating in an actively septic or malnourished patient increases complication risk.

Established Crohn's colitis is generally considered a relative or absolute contraindication to ileal pouch-anal anastomosis at many centers, given higher rates of pouch-related Crohn's complications, though select patients with Crohn's colitis but no small bowel or perianal disease are sometimes considered at experienced centers.